EASTONBIOPHARMACEUTICALS(SH:688513) Xin Lang Cai Jing·2025-09-04 04:30Company Overview - Yuan Dong Bio-pharmaceutical Co., Ltd. is located in Chengdu, Sichuan Province, established on June 1, 2009, and listed on September 2, 2020. The company specializes in the research, production, and sales of chemical raw materials and chemical drug formulations [1] - The main revenue composition includes: 78.75% from formulation sales, 9.22% from raw material sales, 6.79% from technical services and transfers, 4.01% from CMO/CDMO, and 1.22% from other sources [1] Stock Performance - On September 4, Yuan Dong Bio's stock fell by 5.42%, trading at 59.80 yuan per share, with a transaction volume of 86.87 million yuan and a turnover rate of 0.79%. The total market capitalization is 10.557 billion yuan [1] Fund Holdings - Tai Ping Fund has one fund heavily invested in Yuan Dong Bio. The Tai Ping Medical Innovation Mixed Fund A (021027) held 11,500 shares in the second quarter, accounting for 3.27% of the fund's net value, ranking as the tenth largest holding. The estimated floating loss today is approximately 39,400 yuan [2] - The Tai Ping Medical Innovation Mixed Fund A (021027) was established on June 4, 2024, with a latest scale of 13.9827 million yuan. Year-to-date returns are 63.38%, ranking 349 out of 8,180 in its category; one-year returns are 58.77%, ranking 1,728 out of 7,978; and since inception returns are 57.25% [2]